Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Addiction (Abingdon, England)|July 26, 2020
Alcohol use disorder and the liverRyan Buchanan, Julia M A SinclairBMJ Case Reports|June 16, 2012
Prolonged QT interval in bulimia nervosaRyan Buchanan, Joseph Ngwira, Khaled AmshaLiver International : Official Journal of the International Association for the Study of the Liver|December 7, 2020
The combined effect of alcohol and body mass index on risk of chronic liver disease: A systematic review and meta-analysis of cohort studiesKate Glyn-Owen, Dankmar Böhning, Julie Parkes, et al.Harm Reduction Journal|July 13, 2017
Hepatitis C bio-behavioural surveys in people who inject drugs-a systematic review of sensitivity to the theoretical assumptions of respondent driven samplingRyan Buchanan, Salim I Khakoo, Jonathan Coad, et al.Journal of Viral Hepatitis|September 15, 2019
The testing of people with any risk factor for hepatitis C in community pharmacies is cost-effectiveRyan Buchanan, Keith Cooper, Leonie Grellier, et al.BMJ Open|September 29, 2020
Systematic review of the impact of non-alcoholic fatty liver disease on mortality and adverse clinical outcomes for individuals with chronic kidney diseaseTheresa Hydes, Ryan Buchanan, Oliver J Kennedy, et al.The International Journal of Pharmacy Practice|November 8, 2023
Barriers and facilitators experienced in delivering alcohol screening and brief interventions in community pharmacy: a qualitative evidence synthesisAlexander Smith, Ryan Buchanan, Julie Parkes, et al.Journal of Viral Hepatitis|January 24, 2026
Peer Interventions for Hepatitis C Testing and Treatment in OECD Countries: A Systematic Scoping ReviewSorcha Daly, Leila Reid, Ryan Buchanan, et al.The Journal of Infection|December 31, 2019
Prioritising Hepatitis C treatment in people with multiple injecting partners maximises prevention: A real-world network studyRyan Buchanan, Rudabeh Meskarian, Peter van der Heijden, et al.BMJ Open|May 12, 2017
Coffee, including caffeinated and decaffeinated coffee, and the risk of hepatocellular carcinoma: a systematic review and dose-response meta-analysisOliver John Kennedy, Paul Roderick, Ryan Buchanan, et al.Pageof 2